1 – 10 of 14
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2020
- 
                        Mark
        Additive clinical impact of epidermal growth factor receptor and podocalyxin-like protein expression in pancreatic and periampullary adenocarcinomas
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor immune cell composition
    
    - Contribution to journal › Article
 
- 2018
- 
                        Mark
        Expression of programmed cell death protein 1 (PD-1) and its ligand PD-L1 in colorectal cancer : Relationship with sidedness and prognosis
    
    - Contribution to journal › Article
 
- 
                        Mark
        Podocalyxin-like protein as a predictive biomarker for benefit of neoadjuvant chemotherapy in resectable gastric and esophageal adenocarcinoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Pre-diagnostic anthropometry, sex, and risk of colorectal cancer according to tumor-infiltrating immune cell composition
    (2018) In Annals of oncology : official journal of the European Society for Medical Oncology 29(Suppl. 8). p.180-180- Contribution to journal › Published meeting abstract
 
- 2017
- 
                        Mark
        The clinical impact of tumour-infiltrating lymphocytes in colorectal cancer differs by anatomical subsite : A cohort study
    
    - Contribution to journal › Article
 
- 
                        Mark
        Prognostic value of HER3 and HER2 alterations in colorectal cancer: Relationship with sidedness, KRAS and BRAF mutation status
    (2017) European Society of Medical Oncologys annual congress- Contribution to conference › Abstract
 
- 2016
- 
                        Mark
        Expression of podocalyxin-like protein is an independent prognostic biomarker in resected esophageal and gastric adenocarcinoma
    
    - Contribution to journal › Article
 
- 
                        Mark
        Significant association and synergistic adverse prognostic effect of podocalyxin-like protein and epidermal growth factor receptor expression in colorectal cancer
    
    - Contribution to journal › Article
 
- 2015
- 
                        Mark
        Discovery and validation of podocalyxin-like protein as a prognostic biomarker in colorectal cancer
    
    - Thesis › Doctoral thesis (compilation)
 
